☰

Joseph A. Spernyak, Ph.D. - Publications

Affiliations: 
2004 State University of New York, Buffalo, Buffalo, NY, United States 
Area:
General Biophysics, Molecular Biology
Tree Info Similar researchers PubMed Report error

12/69 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Cheruku RR, Turowski SG, Durrani FA, Tabaczynski WA, Cacaccio J, Missert JR, Curtin L, Sexton S, Alberico R, Hendler CM, Spernyak JA, Grossman Z, Pandey RK. Tumor-Avid 3-(1'-Hexyloxy)ethyl-3-devinylpyrpyropheophorbide-a (HPPH)-3Gd(III)tetraxetan (DOTA) Conjugate Defines Primary Tumors and Metastases. Journal of Medicinal Chemistry. PMID 35763292 DOI: 10.1021/acs.jmedchem.2c00547  0.358
2022 Sokolow GE, Crawley MR, Morphet DR, Asik D, Spernyak JA, McGray AJR, Cook TR, Morrow JR. Metal-Organic Polyhedron with Four Fe(III) Centers Producing Enhanced T Magnetic Resonance Imaging Contrast in Tumors. Inorganic Chemistry. 61: 2603-2611. PMID 35073060 DOI: 10.1021/acs.inorgchem.1c03660  0.324
2020 Zhang S, Cheruku R, Dukh M, Tabaczynski W, Patel N, White W, Missert JR, Spernyak JA, Pandey RK. The structure of Gd(III) chelates conjugated at the periphery of 3-(1'-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) make significant impact in imaging and therapy of cancer. Chemmedchem. PMID 32916033 DOI: 10.1002/cmdc.202000449  0.374
2020 Rajab Bolookat E, Malhotra H, Rich LJ, Sexton S, Curtin L, Spernyak JA, Singh AK, Seshadri M. Development and Validation of a Clinically Relevant Workflow for MR-Guided Volumetric Arc Therapy in a Rabbit Model of Head and Neck Cancer. Cancers. 12. PMID 32121562 DOI: 10.3390/Cancers12030572  0.308
2014 Kalra AV, Spernyak J, Kim J, Sengooba A, Klinz S, Paz N, Cain J, Kamoun W, Straubinger N, Qu Y, Trueman S, Bayever E, Nielsen U, Drummond D, Fitzgerald J, et al. Abstract 2065: Magnetic resonance imaging with an iron oxide nanoparticle demonstrates the preclinical feasibility of predicting intratumoral uptake and activity of MM-398, a nanoliposomal irinotecan (nal-IRI) Cancer Research. 74: 2065-2065. DOI: 10.1158/1538-7445.Am2014-2065  0.345
2013 Portwood S, Lal D, Schaefer CW, Uwazurike O, Spernyak JA, Seshadri M, Wang ES. Potent Effects Of The Vascular Disrupting Agent, ASA404 (DMXAA) On The Marrow Microenvironment In Preclinical Human Leukemia and Lymphoma Models Blood. 122: 3953-3953. DOI: 10.1182/BLOOD.V122.21.3953.3953  0.315
2011 Sen A, Capitano ML, Spernyak JA, Schueckler JT, Thomas S, Singh AK, Evans SS, Hylander BL, Repasky EA. Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models. Cancer Research. 71: 3872-80. PMID 21512134 DOI: 10.1158/0008-5472.Can-10-4482  0.301
2010 Spernyak JA, White WH, Ethirajan M, Patel NJ, Goswami L, Chen Y, Turowski S, Missert JR, Batt C, Mazurchuk R, Pandey RK. Hexylether derivative of pyropheophorbide-a (HPPH) on conjugating with 3gadolinium(III) aminobenzyldiethylenetriaminepentaacetic acid shows potential for in vivo tumor imaging (MR, Fluorescence) and photodynamic therapy. Bioconjugate Chemistry. 21: 828-35. PMID 20387862 DOI: 10.1021/Bc9005317  0.367
2005 Bouvet M, Spernyak J, Katz MH, Mazurchuk RV, Takimoto S, Bernacki R, Rustum YM, Moossa AR, Hoffman RM. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer. Cancer Research. 65: 9829-33. PMID 16267005 DOI: 10.1158/0008-5472.Can-05-1548  0.331
2005 Seshadri M, Spernyak JA, Mazurchuk R, Camacho SH, Oseroff AR, Cheney RT, Bellnier DA. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4241-50. PMID 15930363 DOI: 10.1158/1078-0432.Ccr-04-2703  0.346
2005 Mazurchuk R, Spernyak JA. Magnetic resonance imaging of tumor response to chemotherapy. Methods in Molecular Medicine. 111: 381-415. PMID 15911992 DOI: 10.1385/1-59259-889-7:381  0.315
2005 Li G, Slansky A, Dobhal MP, Goswami LN, Graham A, Chen Y, Kanter P, Alberico RA, Spernyak J, Morgan J, Mazurchuk R, Oseroff A, Grossman Z, Pandey RK. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy. Bioconjugate Chemistry. 16: 32-42. PMID 15656573 DOI: 10.1021/Bc049807X  0.394
Low-probability matches (unlikely to be authored by this person)
2010 Goswami LN, White WH, Spernyak JA, Ethirajan M, Chen Y, Missert JR, Morgan J, Mazurchuk R, Pandey RK. Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacy. Bioconjugate Chemistry. 21: 816-27. PMID 20387863 DOI: 10.1021/Bc9005305  0.293
2007 Seshadri M, Spernyak JA, Maiery PG, Cheney RT, Mazurchuk R, Bellnier DA. Visualizing the acute effects of vascular-targeted therapy in vivo using intravital microscopy and magnetic resonance imaging: correlation with endothelial apoptosis, cytokine induction, and treatment outcome. Neoplasia (New York, N.Y.). 9: 128-35. PMID 17356709 DOI: 10.1593/Neo.06748  0.292
2011 Schaefer CW, Lal D, Vethanayagam RR, Spernyak JA, Seshadri M, Wang ES. Anti-Vascular and Anti-Tumor Effects of the Vascular Disrupting Agent ASA404 (DMXAA) in Human Acute Leukemia Xenograft Models Blood. 118: 4293-4293. DOI: 10.1182/BLOOD.V118.21.4293.4293  0.291
2006 Seshadri M, Mazurchuk R, Spernyak JA, Bhattacharya A, Rustum YM, Bellnier DA. Activity of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid against human head and neck carcinoma xenografts. Neoplasia (New York, N.Y.). 8: 534-42. PMID 16867215 DOI: 10.1593/Neo.06295  0.289
2020 Borah BM, Cacaccio J, Durrani FA, Bshara W, Turowski SG, Spernyak JA, Pandey RK. Sonodynamic therapy in combination with photodynamic therapy shows enhanced long-term cure of brain tumor. Scientific Reports. 10: 21791. PMID 33311561 DOI: 10.1038/s41598-020-78153-0  0.289
2011 White W, Spernyak J, Pandey R. Synthesis and characterization of tumor targeted multifunctional agents for photodynamic therapy, MR and optical imaging Photodiagnosis and Photodynamic Therapy. 8: 132. DOI: 10.1016/J.PDPDT.2011.03.035  0.286
2023 Durrani FA, Cacaccio J, Turowski SG, Dukh M, Bshara W, Curtin L, Sexton S, Spernyak JA, Pandey RK. Photobac derived from bacteriochlorophyll-a shows potential for treating brain tumor in animal models by photodynamic therapy with desired pharmacokinetics and limited toxicity in rats and dogs. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 168: 115731. PMID 37857248 DOI: 10.1016/j.biopha.2023.115731  0.285
2008 Seshadri M, Bellnier DA, Vaughan LA, Spernyak JA, Mazurchuk R, Foster TH, Henderson BW. Light delivery over extended time periods enhances the effectiveness of photodynamic therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2796-805. PMID 18451247 DOI: 10.1158/1078-0432.Ccr-07-4705  0.272
2017 Miranda D, Carter K, Luo D, Shao S, Geng J, Li C, Chitgupi U, Turowski SG, Li N, Atilla-Gokcumen GE, Spernyak JA, Lovell JF. Multifunctional Liposomes for Image-Guided Intratumoral Chemo-Phototherapy. Advanced Healthcare Materials. PMID 28504409 DOI: 10.1002/Adhm.201700253  0.246
2024 Roy Chaudhuri T, Lin Q, Stachowiak EK, Rosario SR, Spernyak JA, Ma WW, Stachowiak MK, Greene MK, Quinn GP, McDade SS, Clynes M, Scott CJ, Straubinger RM. Dual-hit strategy for therapeutic targeting of pancreatic cancer in patient-derived xenograft tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38270582 DOI: 10.1158/1078-0432.CCR-23-0131  0.245
2008 Turowski SG, Seshadri M, Loecher M, Podniesinski E, Spernyak JA, Mazurchuk RV. Performance of a novel piezoelectric motor at 4.7 T: applications and initial tests. Magnetic Resonance Imaging. 26: 426-32. PMID 17826943 DOI: 10.1016/j.mri.2007.07.005  0.242
2013 Dorazio SJ, Olatunde AO, Spernyak JA, Morrow JR. CoCEST: cobalt(II) amide-appended paraCEST MRI contrast agents. Chemical Communications (Cambridge, England). 49: 10025-7. PMID 24045271 DOI: 10.1039/C3Cc45000G  0.24
2021 Asik D, Abozeid SM, Turowski SG, Spernyak JA, Morrow JR. Dinuclear Fe(III) Hydroxypropyl-Appended Macrocyclic Complexes as MRI Probes. Inorganic Chemistry. 60: 8651-8664. PMID 34110140 DOI: 10.1021/acs.inorgchem.1c00634  0.238
2019 Snyder EM, Asik D, Abozeid SM, Burgio A, Bateman G, Turowski SG, Spernyak J, Morrow JR. A new class of Fe(III) macrocyclic complexes with alcohol donor groups as effective T1 MRI contrast agents. Angewandte Chemie (International Ed. in English). PMID 31725934 DOI: 10.1002/Anie.201912273  0.237
2016 Shao S, Do TN, Razi A, Chitgupi U, Geng J, Alsop RJ, Dzikovski BG, Rheinstädter MC, Ortega J, Karttunen M, Spernyak JA, Lovell JF. Design of Hydrated Porphyrin-Phospholipid Bilayers with Enhanced Magnetic Resonance Contrast. Small (Weinheim An Der Bergstrasse, Germany). PMID 27739249 DOI: 10.1002/Smll.201602505  0.229
2011 Dorazio SJ, Tsitovich PB, Siters KE, Spernyak JA, Morrow JR. Iron(II) PARACEST MRI contrast agents. Journal of the American Chemical Society. 133: 14154-6. PMID 21838276 DOI: 10.1021/Ja204297Z  0.226
2012 Roy Chaudhuri T, Arnold RD, Yang J, Turowski SG, Qu Y, Spernyak JA, Mazurchuk R, Mager DE, Straubinger RM. Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation. Pharmaceutical Research. 29: 3312-24. PMID 22798260 DOI: 10.1007/S11095-012-0823-4  0.224
2019 Patel A, Asik D, Spernyak JA, Cullen PJ, Morrow JR. MRI and fluorescence studies of Saccharomyces cerevisiae loaded with a bimodal Fe(III) T contrast agent. Journal of Inorganic Biochemistry. 201: 110832. PMID 31522137 DOI: 10.1016/J.Jinorgbio.2019.110832  0.222
2007 Pliss L, Mazurchuk R, Spernyak JA, Patel MS. Brain MR imaging and proton MR spectroscopy in female mice with pyruvate dehydrogenase complex deficiency. Neurochemical Research. 32: 645-54. PMID 17342409 DOI: 10.1007/S11064-007-9295-Z  0.221
2012 Olatunde AO, Dorazio SJ, Spernyak JA, Morrow JR. The NiCEST approach: nickel(II) paraCEST MRI contrast agents. Journal of the American Chemical Society. 134: 18503-5. PMID 23102112 DOI: 10.1021/Ja307909X  0.217
2023 Moloney C, Chaudhuri TR, Spernyak JA, Straubinger RM, Brougham DF. Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition. Acta Biomaterialia. PMID 36603732 DOI: 10.1016/j.actbio.2022.12.057  0.214
2003 Wu M, Mazurchuk R, Chaudhary ND, Spernyak J, Veith J, Pera P, Greco W, Hoffman RM, Kobayashi T, Bernacki RJ. High-resolution magnetic resonance imaging of the efficacy of the cytosine analogue 1-[2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl]-N(4)-palmitoyl cytosine (CS-682) in a liver-metastasis athymic nude mouse model. Cancer Research. 63: 2477-82. PMID 12750269  0.21
2016 Tsitovich PB, Cox JM, Spernyak JA, Morrow JR. Gear Up for a pH Shift: A Responsive Iron(II) 2-Amino-6-picolyl-Appended Macrocyclic paraCEST Agent That Protonates at a Pendent Group. Inorganic Chemistry. 55: 12001-12010. PMID 27934305 DOI: 10.1021/Acs.Inorgchem.6B02159  0.207
2020 Asik D, Smolinski R, Abozeid SM, Mitchell TB, Turowski SG, Spernyak JA, Morrow JR. Modulating the Properties of Fe(III) Macrocyclic MRI Contrast Agents by Appending Sulfonate or Hydroxyl Groups. Molecules (Basel, Switzerland). 25. PMID 32414058 DOI: 10.3390/Molecules25102291  0.204
2021 Abozeid SM, Chowdhury MSI, Asik D, Spernyak JA, Morrow JR. Liposomal Fe(III) Macrocyclic Complexes with Hydroxypropyl Pendants as MRI Probes. Acs Applied Bio Materials. 4: 7951-7960. PMID 35006776 DOI: 10.1021/acsabm.1c00879  0.203
2019 Snyder EM, Asik D, Abozeid SM, Burgio A, Bateman G, Turowski SG, Spernyak JA, Morrow JR. A Class of Fe III Macrocyclic Complexes with Alcohol Donor Groups as Effective T 1 MRI Contrast Agents Angewandte Chemie. 132: 2435-2440. DOI: 10.1002/ange.201912273  0.197
2014 Olatunde AO, Cox JM, Daddario MD, Spernyak JA, Benedict JB, Morrow JR. Seven-coordinate Co(II), Fe(II) and six-coordinate Ni(II) amide-appended macrocyclic complexes as ParaCEST agents in biological media. Inorganic Chemistry. 53: 8311-21. PMID 24820102 DOI: 10.1021/Ic5006083  0.192
2017 Lu Q, Ericson D, Song Y, Zhu C, Ye R, Liu S, Spernyak JA, Du D, Li H, Wu Y, Lin Y. MnO2 Nanotubes-based NanoSearchlight for Imaging of Multiple MicroRNAs in Live Cells. Acs Applied Materials & Interfaces. PMID 28493665 DOI: 10.1021/acsami.6b15387  0.191
2009 Paul AK, Lobarinas E, Simmons R, Wack D, Luisi JC, Spernyak J, Mazurchuk R, Abdel-Nabi H, Salvi R. Metabolic imaging of rat brain during pharmacologically-induced tinnitus. Neuroimage. 44: 312-8. PMID 18948211 DOI: 10.1016/J.Neuroimage.2008.09.024  0.19
2023 Cineus R, Abozeid SM, Sokolow GE, Spernyak JA, Morrow JR. Fe(III) MRI Probes Containing Phenolate or Hydroxypyridine-Appended Triamine Chelates and a Coordination Site for Bound Water. Inorganic Chemistry. 62: 16513-16522. PMID 37748050 DOI: 10.1021/acs.inorgchem.3c02344  0.188
2023 Chowdhury MSI, Kras EA, Turowski SG, Spernyak JA, Morrow JR. Liposomal MRI probes containing encapsulated or amphiphilic Fe(III) coordination complexes. Biomaterials Science. PMID 37470467 DOI: 10.1039/d3bm00029j  0.186
2008 Dominguez I, Yi PH, Sharratt E, Howell G, Spernyak J, Wang J, Brattain M, Rajput A. 101. Characterization of In Vitro and In Vivo Anti-Tumor Activity for a Novel IGF1R Kinase Inbitors on Colon Cancer Cells Journal of Surgical Research. 144: 222-223. DOI: 10.1016/j.jss.2007.12.115  0.184
2021 Damasco JA, Ohulchanskyy TY, Mahajan S, Chen G, Singh A, Kutscher HL, Huang H, Turowski SG, Spernyak JA, Singh AK, Lovell JF, Seshadri M, Prasad PN. Excretable, ultrasmall hexagonal NaGdF:Yb50% nanoparticles for bimodal imaging and radiosensitization. Cancer Nanotechnology. 12: 4. PMID 33603920 DOI: 10.1186/s12645-021-00075-x  0.182
2021 Kras EA, Abozeid SM, Eduardo W, Spernyak JA, Morrow JR. Comparison of phosphonate, hydroxypropyl and carboxylate pendants in Fe(III) macrocyclic complexes as MRI contrast agents. Journal of Inorganic Biochemistry. 225: 111594. PMID 34517167 DOI: 10.1016/j.jinorgbio.2021.111594  0.18
2020 Patel A, Asik D, Snyder EM, Spernyak JA, Cullen PJ, Morrow JR. Saccharomyces cerevisiae and Candida albicans Yeast Cells Labeled with Fe(III) Complexes as MRI Probes Magnetochemistry. 6: 41. DOI: 10.3390/Magnetochemistry6030041  0.18
2004 Bhattacharya A, Tóth K, Mazurchuk R, Spernyak JA, Slocum HK, Pendyala L, Azrak R, Cao S, Durrani FA, Rustum YM. Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8005-17. PMID 15585636 DOI: 10.1158/1078-0432.Ccr-04-1306  0.179
2013 Tsitovich PB, Spernyak JA, Morrow JR. A redox-activated MRI contrast agent that switches between paramagnetic and diamagnetic states. Angewandte Chemie (International Ed. in English). 52: 13997-4000. PMID 24222651 DOI: 10.1002/anie.201306394  0.179
2008 Torres G, Hallas BH, Gross KW, Spernyak JA, Horowitz JM. Magnetic resonance imaging and spectroscopy in a mouse model of schizophrenia. Brain Research Bulletin. 75: 556-61. PMID 18355631 DOI: 10.1016/j.brainresbull.2007.09.006  0.174
2003 Becker MW, Pelc M, Mazurchuk RV, Spernyak J. Magnetic resonance imaging of dense and light non-aqueous phase liquid in a rock fracture Geophysical Research Letters. 30. DOI: 10.1029/2003GL017375  0.164
2011 Riddell JR, Bshara W, Moser MT, Spernyak JA, Foster BA, Gollnick SO. Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculature. Cancer Research. 71: 1637-46. PMID 21343392 DOI: 10.1158/0008-5472.Can-10-3674  0.157
2005 Torres G, Meeder BA, Hallas BH, Spernyak JA, Mazurchuk R, Jones C, Gross KW, Horowitz JM. Ventricular size mapping in a transgenic model of schizophrenia. Brain Research. Developmental Brain Research. 154: 35-44. PMID 15617753 DOI: 10.1016/J.Devbrainres.2004.08.011  0.156
2019 Bond CJ, Cineus R, Nazarenko AY, Spernyak JA, Morrow JR. Isomeric Co(ii) paraCEST agents as pH responsive MRI probes. Dalton Transactions (Cambridge, England : 2003). PMID 31833500 DOI: 10.1039/C9Dt04558A  0.156
2018 Shafirstein G, Bellnier DA, Oakley E, Hamilton S, Habitzruther M, Tworek L, Hutson A, Spernyak JA, Sexton S, Curtin L, Turowski SG, Arshad H, Henderson B. Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer. British Journal of Cancer. PMID 30353043 DOI: 10.1038/S41416-018-0210-Y  0.137
2015 Olatunde AO, Bond CJ, Dorazio SJ, Cox JM, Benedict JB, Daddario MD, Spernyak JA, Morrow JR. Six, Seven or Eight Coordinate Fe(II) , Co(II) or Ni(II) Complexes of Amide-Appended Tetraazamacrocycles for ParaCEST Thermometry. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 26494320 DOI: 10.1002/Chem.201503125  0.135
2020 Xu S, Karthikeyan B, Chen M, Sonkawade SD, Spernyak J, Turowski S, Sharma UC, Pokharel S. Abstract 461: Use of Cardiac Magnetic Resonance Imaging for the Early Detection of Programmed Cell Death-1 Blockade-induced Cardiotoxicity in a Mouse Model Circulation Research. 127. DOI: 10.1161/res.127.suppl_1.461  0.12
2023 Sonkawade SD, Xu S, Kim M, Nepali S, Karambizi VG, Sexton S, Turowski SG, Li K, Spernyak JA, Lovell JF, George A, Suwal S, Sharma UC, Pokharel S. Phospholipid Encapsulation of an Anti-Fibrotic Endopeptide to Enhance Cellular Uptake and Myocardial Retention. Cells. 12. PMID 37371059 DOI: 10.3390/cells12121589  0.117
2018 Sharma UC, Sonkawade SD, Spernyak JA, Sexton S, Nguyen J, Dahal S, Attwood KM, Singh AK, van Berlo JH, Pokharel S. A Small Peptide Ac-SDKP Inhibits Radiation-Induced Cardiomyopathy. Circulation. Heart Failure. 11: e004867. PMID 30354563 DOI: 10.1161/Circheartfailure.117.004867  0.113
2021 Anandakrishnan N, Ye H, Guo Z, Chen Z, Mentkowski KI, Lang JK, Rajabian N, Andreadis ST, Ma Z, Spernyak JA, Lovell JF, Wang D, Xia J, Zhou C, Zhao R. Fast Stereolithography Printing of Large-Scale Biocompatible Hydrogel Models. Advanced Healthcare Materials. e2002103. PMID 33586366 DOI: 10.1002/adhm.202002103  0.112
2018 Sharma UC, Sonkawade SD, Baird A, Chen M, Xu S, Sexton S, Singh AK, Groman A, Turowski SG, Spernyak JA, Mahajan SD, Pokharel S. Effects of a novel peptide Ac-SDKP in radiation-induced coronary endothelial damage and resting myocardial blood flow. Cardio-Oncology (London, England). 4. PMID 31057947 DOI: 10.1186/s40959-018-0034-1  0.1
2015 Tutino VM, Liaw N, Spernyak JA, Ionita CN, Siddiqui AH, Kolega J, Meng H. Assessment of Vascular Geometry for Bilateral Carotid Artery Ligation to Induce Early Basilar Terminus Aneurysmal Remodeling in Rats. Current Neurovascular Research. PMID 26503026 DOI: 10.2174/1567202612666151027143149  0.091
2007 Jell J, Merali S, Hensen ML, Mazurchuk R, Spernyak JA, Diegelman P, Kisiel ND, Barrero C, Deeb KK, Alhonen L, Patel MS, Porter CW. Genetically altered expression of spermidine/spermine N1- acetyltransferase affects fat metabolism in mice via acetyl-CoA Journal of Biological Chemistry. 282: 8404-8413. PMID 17189273 DOI: 10.1074/Jbc.M610265200  0.088
2009 Chintala S, Novak EK, Spernyak JA, Mazurchuk R, Torres G, Patel S, Busch K, Meeder BA, Horowitz JM, Vaughan MM, Swank RT. The Vps33a gene regulates behavior and cerebellar Purkinje cell number. Brain Research. 1266: 18-28. PMID 19254700 DOI: 10.1016/J.Brainres.2009.02.035  0.088
2024 Li WJ, Wang Y, Liu X, Wu S, Wang M, Turowski SG, Spernyak JA, Tracz A, Abdelaal AM, Sudarshan K, Puzanov I, Chatta G, Kasinski AL, Tang DG. Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises. International Journal of Molecular Sciences. 25. PMID 38396800 DOI: 10.3390/ijms25042123  0.083
2021 King G, Veros KM, MacLaren DAA, Leigh MPK, Spernyak JA, Clark SD. Human wildtype tau expression in cholinergic pedunculopontine tegmental neurons is sufficient to produce PSP-like behavioural deficits and neuropathology. The European Journal of Neuroscience. PMID 34668254 DOI: 10.1111/ejn.15496  0.078
2021 Anandakrishnan N, Ye H, Guo Z, Chen Z, Mentkowski KI, Lang JK, Rajabian N, Andreadis ST, Ma Z, Spernyak JA, Lovell JF, Wang D, Xia J, Zhou C, Zhao R. 3D Bioprinting: Fast Stereolithography Printing of Large‐Scale Biocompatible Hydrogel Models (Adv. Healthcare Mater. 10/2021) Advanced Healthcare Materials. 10: 2170051. DOI: 10.1002/ADHM.202170051  0.077
2022 Kumar R, Chaudhary AK, Woytash J, Inigo JR, Gokhale AA, Bshara W, Attwood K, Wang J, Spernyak JA, Rath E, Yadav N, Haller D, Goodrich DW, Tang DG, Chandra D. A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60. The Journal of Clinical Investigation. PMID 35653190 DOI: 10.1172/JCI149906  0.056
2021 Sonkawade SD, Pokharel S, Karthikeyan B, Kim M, Xu S, Kc K, Sexton S, Catalfamo K, Spernyak JA, Sharma UC. Small Endogeneous Peptide Mitigates Myocardial Remodeling in a Mouse Model of Cardioselective Galectin-3 Overexpression. Circulation. Heart Failure. CIRCHEARTFAILURE1210. PMID 34415177 DOI: 10.1161/CIRCHEARTFAILURE.121.008510  0.04
Hide low-probability matches.